I would agree with you, but then our Key director sold a lot of stock in November to lock-in that capital gain. Geeez, wouldn't it be nice if someone composed an e-mail to explain his sell. I think companies often tell investors why a director sold...keeps the natives happy at the Tiki Bar ( Oh brother are you people for real ? )
What would you do if you had what could very well become the next go to treatment for bladder cancer ?
BCG is so toxic most ( 70% ) can't tolerate the full treatment cycle.
We've had two phase III trials, the last one was stopped at the beginning of tax loss season and we've heard NOTHING about it.
Now they are going back to the FDA in the US again ?
What would you do with BNC ( at 30 cents ) dump it into say ENDO ( now $80 ) and have ENDO go to $145 because they've added a blockbuster 1 BILLION / year revenue in a MUCH needed bladder cancer product ?
I might keep the little stick of dynamite in my pocket and print 70 or 100MM shares and then let it go from say .30 to $3 or $10 or $20 ?
You kids seem to be challenged when it comes to how rockstar CEO's from massive companies think.......They think LARGE...let's talk more about the burn on the VMC ( you're being had peeps )
Read more at
https://www.stockhouse.com/companies/bullboard/t.bnc/bioniche-life-sciences-inc#VQED7YtOLGw4xea6.99